Not every assay needs the same substrate. But every assay needs the right one.

In recent years, the country has promulgated centralized bulk-buying policy for high value medical consumables in the field of medical devices.

April 5, 2022 – GE Healthcare and Elekta (EKTA-B.ST) announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology.

On 28 March, Sanxing Medical Electric Co., Ltd. (601566.SH), made several announcements announcing that its subsidiary, Rehabilitation Investment, intended to acquire 100% of the equity interests in five hospitals for a total price of CNY 844 million.

UK life science tools company LGC said on Friday that it has acquired Rapid Genomics, a next-generation sequencing genotyping company based in Gainesville, Florida.

Agilent Technologies on Tuesday announced it has obtained expanded CE-IVD marking for the use of its PD-L1 IHC 28-8 pharmDx immunohistochemical assay as a companion diagnostic test to guide treatment for newly approved indications for Bristol Myers Squibb's Opdivo.

Jinan Babio Biotechnology Co., Ltd. recently received an official notification from the EU Notified Body for its self-tested novel coronavirus antigen detection product, and subsequently obtained the CE certification issued by PCBC.

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

Israeli diagnostics firm Todos Medical on Friday reported a nearly 13 percent year-over-year increase in revenues for the fourth quarter on increased demand for its COVID-19 testing products and services, as well as nutritional supplements.

On March 30, China National Medical Device Co., Ltd. (CNMD for short) under Sinopharm Group and Suzhou Hybiome Biomedical Engineering Co. Ltd., subsidiary of BioMerieux in China held a signing ceremony of the strategic cooperation agreement.

HTG Molecular Diagnostics reported after the close of the market on Tuesday that its 2021 revenues edged up 5 percent to $8.9 million from $8.5 million a year ago.

A recent study published in Nature Genetics identified 10 new genetic regions associated with Brugada syndrome, a cardiac arrhythmia disorder associated with sudden death in young adults.